Abstract
Atherosclerosis is a chronic process related to several underlying mechanisms leading to the formation and evolution of atherosclerotic plaque. Of great interest are during the last years short, non-coding RNAs, called microRNAs and responsible for several aspects of homeostasis and disease. According to the available data microRNAs are expressed in the cardiovascular system and have key roles in normal states, as well as in disease development and progression. Moreover, it has been shown that they contribute to atherogenesis, coronary artery disease and myocardial infarction. Importantly, microRNAs circulate in the bloodstream, while they exist in tissues, affect plaque initiation and progression and seem to be essential biomarkers of atherosclerosis. Therefore, understanding the role of these molecules may be of great importance in the understanding of the pathogenesis of atheromatous plaque providing new evidence for diagnosis and treatment of atherosclerosis and its' clinical presentation.
Keywords: miRNAs, atherosclerosis, plaque progression, non-coding RNAs, homeostasis, coronary artery disease, myocardial infarction, biomarkers, cardiovascular system, plaque initiation
Current Pharmaceutical Design
Title:The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque
Volume: 19 Issue: 9
Author(s): Nikolaos Papageorgiou, Dimitris Tousoulis, Emmanuel Androulakis, Anna Kontogeorgou, Marietta Charakida, Anastasios Giolis, Katerina Siama, Athanasios Trikas, Alexandros Briasoulis, Christos Pitsavos and Christodoulos Stefanadis
Affiliation:
Keywords: miRNAs, atherosclerosis, plaque progression, non-coding RNAs, homeostasis, coronary artery disease, myocardial infarction, biomarkers, cardiovascular system, plaque initiation
Abstract: Atherosclerosis is a chronic process related to several underlying mechanisms leading to the formation and evolution of atherosclerotic plaque. Of great interest are during the last years short, non-coding RNAs, called microRNAs and responsible for several aspects of homeostasis and disease. According to the available data microRNAs are expressed in the cardiovascular system and have key roles in normal states, as well as in disease development and progression. Moreover, it has been shown that they contribute to atherogenesis, coronary artery disease and myocardial infarction. Importantly, microRNAs circulate in the bloodstream, while they exist in tissues, affect plaque initiation and progression and seem to be essential biomarkers of atherosclerosis. Therefore, understanding the role of these molecules may be of great importance in the understanding of the pathogenesis of atheromatous plaque providing new evidence for diagnosis and treatment of atherosclerosis and its' clinical presentation.
Export Options
About this article
Cite this article as:
Papageorgiou Nikolaos, Tousoulis Dimitris, Androulakis Emmanuel, Kontogeorgou Anna, Charakida Marietta, Giolis Anastasios, Siama Katerina, Trikas Athanasios, Briasoulis Alexandros, Pitsavos Christos and Stefanadis Christodoulos, The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque, Current Pharmaceutical Design 2013; 19 (9) . https://dx.doi.org/10.2174/1381612811319090012
DOI https://dx.doi.org/10.2174/1381612811319090012 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Cabergoline on Cognitive Impairments in Transgenic <i>Drosophila</i> Model of Parkinson’s Disease
Letters in Drug Design & Discovery Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Antiproliferative Activity of Cobra Venom Cytotoxins
Current Topics in Medicinal Chemistry Editorial (Hot Topic: Cardiovascular Disease Biomarkers: from Tradition to Modernity)
Current Topics in Medicinal Chemistry Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions
Current Drug Metabolism Editorial [Hot topic: Drug-Induced QT Interval Prolongation: Clinical, Safety and Regulatory Update (Guest Editor: Guillermo Di Girolamo)]
Current Drug Safety Myokines in Myogenesis and Health
Recent Patents on Biotechnology Atrial and Brain Natriuretic Peptides- Benefits and Limits of their use in Cardiovascular Diseases
Current Cardiology Reviews Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations
CNS & Neurological Disorders - Drug Targets Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews Discovery of Small Molecule Inhibitors for Prevention of Complement- Mediated Immune Hemolysis
Drug Design Reviews - Online (Discontinued) Ethnic Differences in Pharmacogenetically Relevant Genes
Current Drug Targets Endogenous Ligand Bias by Chemokines: Implications at the Front Lines of Infection and Leukocyte Trafficking
Endocrine, Metabolic & Immune Disorders - Drug Targets The Immunologic Barriers to Replacing Damaged Organs
Current Immunology Reviews (Discontinued) Development of Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology to Facilitate Drug Discovery and Translational Medicine
Current Bioinformatics <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Applications of Michael Addition Reaction in Organic Synthesis
Current Organic Synthesis Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews